Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG - HSA Drug Approval Details

Approvals/HSA/PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

Approved

THERAPEUTIC

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

Gland Pharma Limited🇸🇬 Health Sciences Authority

Approval Date: Mar 11, 2020
Approval ID: 0b94d5140357f730
Company: Gland Pharma Limited
Type: Therapeutic

Approval Details

Approval Id: 0b94d5140357f730
Drug Name: PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG
Product Name: PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG
Approval Number: SIN15900P
Approval Date: 2020-03-11
Registrant: PFIZER PRIVATE LIMITED
Licence Holder: PFIZER PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route Of Administration: INTRAVENOUS, SUBCUTANEOUS
Atc Code: L01XX32
Atc Item Name: xl 01 xx 32
Pharma Manufacturer Name: PFIZER PRIVATE LIMITED
Company Detail Path: /organization/95690f7e03ef4227/pfizer-private-limited

Active Ingredients

Bortezomib (as a mannitol boronic ester)

3.50mg

Bortezomib (as a mannitol boronic ester)

3.50mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 11, 2020

Approval ID

0b94d5140357f730

Type

Therapeutic

Back to HSA Approvals